KORU Medical Systems, Inc. - Common Stock (KRMD)

Record quarterly revenue and first profitable quarter since 2019 signal momentum.

KORU Medical Systems (NASDAQ:KRMD) reported second-quarter revenue of $12 million, up 18% from a year earlier, as domestic patient starts, market-share gains and international demand supported growth. The company also said it achieved positive net income for the first time since 2019 and raised its

Koru Medical (KRMD) Q1 2026 Earnings Transcript

KORU Medical (KRMD) Q4 2025 Earnings Transcript

As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

KRMD stock results show that KORU Medical Systems beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Although speculation can be bad for your blood pressure, these compelling penny stocks have some strong endorsements.

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.